Perfil
Ted Dolan is currently the Chief Operating Officer at BioVectra, Inc. He was previously the Chief Operating Officer at Alcami Corp., Inc. and the President, Treasurer & Secretary at Dr. Resolution, Inc.
Cargos activos de Ted Dolan
| Empresas | Cargo | Inicio |
|---|---|---|
BioVectra, Inc.
BioVectra, Inc. BiotechnologyHealth Technology Operates as a contract development and manufacturing organization that specializes in clinical-to-commercial scale production for biologics, small molecules, bioreagents and lipids | Director de Operaciones | 01/09/2020 |
Antiguos cargos conocidos de Ted Dolan.
| Empresas | Cargo | Fin |
|---|---|---|
Dr. Resolution, Inc.
Dr. Resolution, Inc. Packaged SoftwareTechnology Services Develops software for discovering and managing unstructured data | Presidente | 01/01/2013 |
Alcami Corp., Inc.
Alcami Corp., Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceuticals and biotechnology products contract development, manufacturing, packaging and pharmaceutical support activities | Director de Operaciones | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Alcami Corp., Inc.
Alcami Corp., Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceuticals and biotechnology products contract development, manufacturing, packaging and pharmaceutical support activities | Health Technology |
Dr. Resolution, Inc.
Dr. Resolution, Inc. Packaged SoftwareTechnology Services Develops software for discovering and managing unstructured data | Technology Services |
BioVectra, Inc.
BioVectra, Inc. BiotechnologyHealth Technology Operates as a contract development and manufacturing organization that specializes in clinical-to-commercial scale production for biologics, small molecules, bioreagents and lipids | Health Technology |
- Bolsa de valores
- Insiders
- Ted Dolan
















